Authors:
Harada, M
Li, YF
El-Gamil, M
Ohnmacht, GA
Rosenberg, SA
Robbins, PF
Citation: M. Harada et al., Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types, J IMMUNOTH, 24(4), 2001, pp. 323-333
Authors:
Zeng, G
Wang, X
Robbins, PF
Rosenberg, SA
Wang, RF
Citation: G. Zeng et al., CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production, P NAS US, 98(7), 2001, pp. 3964-3969
Authors:
Lapointe, R
Royal, RE
Reeves, ME
Altomare, I
Robbins, PF
Hwu, P
Citation: R. Lapointe et al., Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100, J IMMUNOL, 167(8), 2001, pp. 4758-4764
Authors:
Housseau, F
Moorthy, A
Langer, DA
Robbins, PF
Gonzales, MI
Topalian, SL
Citation: F. Housseau et al., N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells, EUR J IMMUN, 31(9), 2001, pp. 2690-2701
Authors:
Harada, M
Li, YF
El-Gamil, M
Rosenberg, SA
Robbins, PF
Citation: M. Harada et al., Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A0201-restricted T cells, CANCER RES, 61(3), 2001, pp. 1089-1094
Authors:
Touloukian, CE
Leitner, WW
Robbins, PF
Rosenberg, SA
Restifo, NP
Citation: Ce. Touloukian et al., Mining the melanosome for tumor vaccine targets: P. polypeptide is a noveltumor-associated, CANCER RES, 61(22), 2001, pp. 8100-8104
Authors:
Kawakami, Y
Dang, N
Wang, X
Tupesis, J
Robbins, PF
Wang, RF
Wunderlich, JR
Yannelli, JR
Rosenberg, SA
Citation: Y. Kawakami et al., Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma, J IMMUNOTH, 23(1), 2000, pp. 17-27
Authors:
Touloukian, CE
Leitner, WW
Topalian, SL
Li, YF
Robbins, PF
Rosenberg, SA
Restifo, NP
Citation: Ce. Touloukian et al., Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice, J IMMUNOL, 164(7), 2000, pp. 3535-3542
Authors:
Clay, TM
Custer, MC
McKee, MD
Parkhurst, M
Robbins, PF
Kerstann, K
Wunderlich, J
Rosenberg, SA
Nishimura, MI
Citation: Tm. Clay et al., Changes in the fine specificity of gp100((209-217))-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue, J IMMUNOL, 162(3), 1999, pp. 1749-1755
Authors:
Nishimura, MI
Avichezer, D
Custer, MC
Lee, CS
Chen, C
Parkhurst, MR
Diamond, RA
Robbins, PF
Schwartzentruber, DJ
Rosenberg, SA
Citation: Mi. Nishimura et al., MHC class I-restricted recognition of a melanoma antigen by a human CD4(+)tumor infiltrating lymphocyte, CANCER RES, 59(24), 1999, pp. 6230-6238
Authors:
Irvine, KR
Parkhurst, MR
Shulman, EP
Tupesis, JP
Custer, M
Touloukian, CE
Robbins, PF
Yafal, AG
Greenhalgh, P
Sutmuller, RPM
Offringa, R
Rosenberg, SA
Restifo, NP
Citation: Kr. Irvine et al., Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens, CANCER RES, 59(11), 1999, pp. 2536-2540
Authors:
Kawakami, Y
Robbins, PF
Wang, X
Tupesis, JP
Parkhurst, MR
Kang, XQ
Sakaguchi, K
Appella, E
Rosenberg, SA
Citation: Y. Kawakami et al., Identification of new melanoma epitopes on melanosomal proteins recognizedby tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles, J IMMUNOL, 161(12), 1998, pp. 6985-6992